How does the choice of kidney substitution therapy (dialysis vs transplant) impact the clinical outcomes of intoxicated patients?
Best insight from top research papers
The choice of kidney substitution therapy, whether dialysis or transplant, significantly impacts the clinical outcomes of intoxicated patients. Studies have shown that kidney transplantation is considered the best renal replacement therapy, offering better survival rates compared to dialysis . Patients transitioning from hemodialysis to peritoneal dialysis have shown improved outcomes, including reduced mortality and increased access to transplantation . Additionally, the combination of hemodialysis with conventional treatment and naloxone has been found to reduce hospital stay, coma time, and overall complication rates in patients with acute severe alcohol intoxication . However, the decision to opt for kidney transplantation may be influenced by factors such as lack of information, age, contraindications, and perceptions of outcomes . Ultimately, the choice between dialysis and transplant plays a crucial role in determining the clinical outcomes of intoxicated patients.
Answers from top 4 papers
More filters
| Papers (4) | Insight |
|---|---|
| Not addressed in the paper. | |
| Not addressed in the paper. | |
| Not addressed in the paper. | |
| Not addressed in the paper. |
Related Questions
How chronic kidney disease (CKD) can influence the toxicological effects of drugs primarily excreted by the kidneys?4 answersChronic kidney disease (CKD) can significantly impact the toxicological effects of drugs primarily excreted by the kidneys. Patients with CKD may experience altered pharmacokinetic profiles due to changes in drug metabolism and transport processes in the kidneys and liver. Uremic toxins and inflammatory cytokines associated with CKD can affect the activity and expression levels of drug-metabolizing enzymes and transporters, potentially leading to fluctuations in drug concentrations and toxicity. Some drugs, like proton pump inhibitors, antibiotics, and diuretics, are known to cause nephrotoxicity and may exacerbate CKD progression. Therefore, close monitoring and dosage adjustments are crucial to mitigate the risk of drug-induced harm in CKD patients.
How does hemodialysis affect intoxication levels in ICU patients?5 answersHemodialysis plays a crucial role in reducing intoxication levels in ICU patients with severe toxic ingestions. Studies have shown that hemodialysis can effectively expedite the clearance of toxic substances like ethanol, valproic acid, toxic alcohols, and hydrofluoric acid. In cases of severe intoxication, where traditional treatments may not suffice, hemodialysis has been proven to be beneficial in improving neurological status, preventing organ damage, and aiding in the elimination of toxic byproducts. Furthermore, high-volume dialysis systems have been successfully utilized in the ICU setting, demonstrating enhanced efficacy and cost-effectiveness in treating life-threatening intoxications. Overall, hemodialysis emerges as a valuable therapeutic intervention for managing intoxication levels in critically ill patients, showcasing its effectiveness in enhancing patient outcomes and preventing further complications.
Do laboratory related factors affect the outcomes of dialysis patients?5 answersLaboratory related factors have been found to affect the outcomes of dialysis patients. Several studies have shown that certain laboratory parameters are associated with increased mortality in hemodialysis patients. These parameters include serum calcium levels, intact parathyroid hormone (iPTH) levels, C-reactive protein (CRP), neutrophil count, lactate dehydrogenase (LDH), white blood cell count, albumin levels, and blood urea nitrogen (BUN) levels. Additionally, variability in these laboratory parameters has also been found to be associated with increased mortality, particularly in non-cardiac deaths. These findings suggest that monitoring and managing these laboratory parameters in dialysis patients may be important for improving outcomes and reducing mortality rates.
What impact will problems with kidney dialysis have on people?5 answersProblems with kidney dialysis can have a significant impact on people. Dialysis users often experience restrictions in their ability to engage in social, intellectual, and physical activities, leading to a decrease in their quality of life. Patients with end-stage renal disease (ESRD) undergoing hemodialysis are at risk of developing psychiatric disorders such as depression and anxiety, which can further worsen their emotional well-being. Additionally, disruptions in dialysis delivery due to unexpected calamities like natural disasters or pandemics can have severe consequences for patients, including a higher risk of mortality and limited access to essential healthcare services. The psychosocial impacts of chronic kidney disease (CKD) and dialysis therapy can also lead to feelings of anxiety, difficulty adjusting to dialysis, financial strain, and neglect of important activities in life. Overall, problems with kidney dialysis can have a detrimental effect on patients' mental health, quality of life, and overall well-being.
What is the impact of donor specific antibody in kidney transplant outcomes?5 answersThe impact of donor-specific antibodies (DSAs) on kidney transplant outcomes is still unclear. Some studies suggest that the presence of preformed DSAs may increase the risk of rejection and graft dysfunction, while others indicate that highly sensitive assays for detecting DSAs may not necessarily impact long-term graft outcomes. However, other studies have found that the presence of DSAs, especially those with C1q-binding capacity, is associated with inferior kidney graft outcomes, including a decline in estimated glomerular filtration rate and death-censored graft loss. It has also been observed that the persistence of preformed DSAs and the development of de novo DSAs are associated with inferior long-term allograft outcomes. Additionally, low-level DSAs detected by Luminex but negative flow cytometric crossmatch (PLNF) results have shown mixed effects on kidney transplantation outcomes, with some studies reporting an increased risk of antibody-mediated rejection and graft failure. Overall, the impact of DSAs on kidney transplant outcomes may vary depending on various factors and should be individually evaluated.
What is the cause of death in CKD patients?5 answersThe leading cause of death in patients with chronic kidney disease (CKD) is cardiovascular disease (CVD). Traditional risk factors for atherosclerosis and arteriosclerosis, such as age, hypertension, dyslipidemia, diabetes mellitus, and smoking, contribute to the increased incidence of CVD in CKD patients. Additionally, CKD-specific risk factors, such as CKD-mineral and bone disorder (CKD-MBD), play a role in CVD pathogenesis. CKD-MBD is characterized by abnormalities in calcium, phosphate, and fibroblast growth factor 23 (FGF23) levels, which can lead to left ventricular hypertrophy, arrhythmia, and cardiovascular calcification. Other factors that contribute to cardiovascular mortality in CKD patients include electrolyte shifts, divalent ion abnormalities, sympathetic overactivity, iron toxicity, and chronic inflammation. In advanced stages of CKD, sudden cardiac death (SCD) becomes a significant risk, which may be exacerbated by electrolyte shifts and other factors. Overall, CVD is the primary cause of death in CKD patients, and addressing both traditional and CKD-specific risk factors is crucial in preventing cardiovascular mortality in this population.